Why the FDA’s plan to use one pagers will fail

Send us Fan MailFDA is suggesting the use of one-pagers to provide essential drug information to patients. Past attempts faced challenges, such as one-size-fits-all content and patient trust issues.  Darshan emphasizes that while the FDA's proposal is a step in the right direction, it must ensure that these one-pagers are comprehensive, accurate, and transparent. Patients often rely on healthcare providers and trusted sources like WebMD for drug information. This short explores the potential benefits and concerns surrounding this FDA initiative, stressing the need for precise and reliable drug information.Support the showwww.kulkarnilawfirm.com